These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4520108)

  • 1. The relationship between red cell acetylcholinesterase activity and Ii antigenicity in leukaemia.
    Scott GL; Dornhorst A; Rasbridge MR
    Scand J Haematol; 1973; 11(3):230-5. PubMed ID: 4520108
    [No Abstract]   [Full Text] [Related]  

  • 2. Red blood cell acetylcholinesterase activity and lysis in various dyshaemopoietic disorders.
    Stathakis N; Papayannis AG; Scliros P; Gardikas C
    Scand J Haematol; 1973; 11(3):210-6. PubMed ID: 4765536
    [No Abstract]   [Full Text] [Related]  

  • 3. Muramidase activity in leukemia and myeloproliferative disorders.
    Skarin AT; Matsuo Y; Moloney WC
    Oncology; 1973; 27(5):406-14. PubMed ID: 4515747
    [No Abstract]   [Full Text] [Related]  

  • 4. [Quantitative assay of RBC antigens I and i in pathology (author's transl)].
    Rochant H; Tonthat H; Man NM; Lefaou J; Henri A; Dreyfus B
    Nouv Rev Fr Hematol; 1973; 13(3):307-18. PubMed ID: 4270585
    [No Abstract]   [Full Text] [Related]  

  • 5. Red cell acetylcholinesterase deficiency in ABO hemolytic disease of the newborn.
    Herz F; Kaplan E; Scheye ES
    Clin Chim Acta; 1972 Feb; 36(2):537-42. PubMed ID: 4621511
    [No Abstract]   [Full Text] [Related]  

  • 6. CELL ANTIGENS AND CELL SPECIALIZATION. II. DEMONSTRATION OF SOME RED CELL ANTIGENS OF HUMAN NORMOBLASTS.
    YUNIS JJ; YUNIS EJ
    Blood; 1964 Nov; 24():522-30. PubMed ID: 14236727
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythrocyte pyruvate kinase activity in patients with haematological malignancies.
    Tanphaichitr VS; van Eys J
    Scand J Haematol; 1975 Aug; 15(1):10-6. PubMed ID: 1058525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The activity of erythrocytic enzymes in akute leukaemia (author's transl)].
    Vives-Corrons JL; Carreras MD; Brugues RM; Florensa L; Pujades MA; Rozman C
    Sangre (Barc); 1978; 23(4):426-37. PubMed ID: 280000
    [No Abstract]   [Full Text] [Related]  

  • 9. The fibrinolytic enzyme system in leukaemia, myelomatosis and myeloproliferative diseases.
    Ogston D; Dawson AA; Adam HM
    Acta Haematol; 1972; 48(6):322-30. PubMed ID: 4633099
    [No Abstract]   [Full Text] [Related]  

  • 10. [Frequency of changes involving A, B, and P1 erythrocyte antigens in myelomonocytic syndromes in children].
    Reviron J; Schenmetzler C; Weisgerber C; Bernard J
    Rev Fr Transfus; 1970 Sep; 13(3):251-9. PubMed ID: 5278232
    [No Abstract]   [Full Text] [Related]  

  • 11. Acetylcholinesterase activity in En(a-) red cells.
    Herz F; Kaplan E; Furuhjelm U
    Vox Sang; 1972; 23(3):228-31. PubMed ID: 5076134
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple red cell antigen loss in acute granulocytic leukemia.
    Kolins J; Holland PV; McGinniss MH
    Cancer; 1978 Nov; 42(5):2248-53. PubMed ID: 281259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The erythrocyte blood group antigens of human malignant (undifferentiated) cells.
    Yunis EJ; Hallgren HM; Svardal JM
    Bibl Haematol; 1968; 29():345-51. PubMed ID: 5248958
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of immune reactions on the red cell membrane.
    Rosse WF; Lauf PK
    Semin Hematol; 1970 Jul; 7(3):323-40. PubMed ID: 4193308
    [No Abstract]   [Full Text] [Related]  

  • 15. On the I antigen of red cells in leukemia and its interaction with Mycoplasmas in vitro and in vivo.
    Altucci P; Buonanno G; Cocco F; De Vargas F; Varone GL
    Acta Haematol; 1968; 40(3):134-41. PubMed ID: 4975041
    [No Abstract]   [Full Text] [Related]  

  • 16. The antigen content of "inagglutinable" group B erythrocytes.
    Winkelstein JA; Mollison PL
    Vox Sang; 1965; 10(5):614-26. PubMed ID: 5864818
    [No Abstract]   [Full Text] [Related]  

  • 17. Red cell creatine & acetylcholine esterase in iron deficiency anaemia.
    Ramachandran M; Iyer GY
    Indian J Biochem Biophys; 1982 Aug; 19(4):290-1. PubMed ID: 7166338
    [No Abstract]   [Full Text] [Related]  

  • 18. Human erythrocyte acetylcholinesterase bears the Yta blood group antigen and is reduced or absent in the Yt(a-b-) phenotype.
    Rao N; Whitsett CF; Oxendine SM; Telen MJ
    Blood; 1993 Feb; 81(3):815-9. PubMed ID: 8427972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infection resistance in hemoblastoses, functional studies on leukocyte mobilization in healthy and sick subjects].
    Senn H
    Exp Med Pathol Klin; 1972; 36():1-110. PubMed ID: 4559715
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence that the antigens of the Yt blood group system are located on human erythrocyte acetylcholinesterase.
    Spring FA; Gardner B; Anstee DJ
    Blood; 1992 Oct; 80(8):2136-41. PubMed ID: 1391965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.